BioNTech SE (BNTX) vs Quest Diagnostics Incorporated (DGX)
A side-by-side comparison of BioNTech SE and Quest Diagnostics Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 10, 2026. Differences are shown without an overall score or investment verdict.
BNTX
BioNTech SE
$93.10HealthcareDelayed quote: Aug 10, 2026, 1:20 PM EDT
DGX
Quest Diagnostics Incorporated
$237.62HealthcareDelayed quote: Aug 10, 2026, 1:20 PM EDT
Total return — BNTX vs DGX
growth of $100 · dividends reinvested · last 7yBNTX +566.6% (+31.1%/yr)DGX +163.1% (+14.8%/yr)BNTX compounded faster over this window
BNTX DGX
BNTX vs DGX: by the numbers
- •DGX is the larger company ($26.23B vs $23.39B market cap).
- •DGX is profitable (9.19% net margin) while BNTX runs a net loss (-44.73%).
- •BNTX grew revenue faster over the past five years (2.16% vs 0.89% CAGR).
- •DGX pays a dividend (1.39% yield), while BNTX is a former payer with no current dividend run rate.
Metrics side by side
Valuation
| Metric | BNTX | DGX |
|---|---|---|
| P/E ratio | N/A | 25.30 |
| Forward P/E | N/A | 21.30 |
| P/S ratio | 7.21 | 2.31 |
| P/B ratio | 1.10 | 3.55 |
| EV / EBITDA | N/A | 16.25 |
| FCF yield | 6.31% | 4.57% |
Profitability
| Metric | BNTX | DGX |
|---|---|---|
| Gross margin | 73.26% | 33.15% |
| Operating margin | -22.63% | 14.14% |
| Net margin | -44.73% | 9.19% |
| ROE | -6.79% | 14.13% |
| ROIC | -3.14% | 8.43% |
Dividends
| Metric | BNTX | DGX |
|---|---|---|
| Dividend yield | N/A | 1.39% |
| Payout ratio | N/A | 37.43% |
Growth (annualized)
| Metric | BNTX | DGX |
|---|---|---|
| Revenue CAGR (5Y) | 2.16% | 0.89% |
| EPS CAGR (5Y) | N/A | -3.65% |
| FCF CAGR (5Y) | N/A | -10.89% |
| Total return CAGR (5Y) | -24.57% | 12.37% |
Frequently asked
- Which has grown faster, BNTX or DGX?
- Over the past five years, BNTX grew revenue faster — BNTX at a 2.16% CAGR versus DGX at 0.89%.
- Does BNTX or DGX pay a bigger dividend?
- DGX pays a dividend (1.39% yield), while BNTX is a former payer with no current dividend run rate.
- Is BNTX or DGX more profitable?
- DGX runs the higher net margin — BNTX at -44.73% versus DGX at 9.19%.
- How have BNTX and DGX total returns compared?
- Over the past 5 years, BNTX delivered -24.57% and DGX delivered 12.97% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Quest Diagnostics P/E ratioQuest Diagnostics dividend yieldBioNTech SE ROEQuest Diagnostics ROEBioNTech SE operating marginQuest Diagnostics operating marginBioNTech SE revenue growthQuest Diagnostics revenue growthBioNTech SE free cash flowQuest Diagnostics free cash flow
BioNTech SE & Quest Diagnostics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 10, 2026.